{"id":28947,"date":"2026-04-02T14:17:02","date_gmt":"2026-04-02T14:17:02","guid":{"rendered":"https:\/\/www.medicalbillersandcoders.com\/blog\/?post_type=wpseo_locations&p=28947"},"modified":"2026-04-02T14:19:03","modified_gmt":"2026-04-02T14:19:03","slug":"obgyn-billing-in-texas-facing-rising-modifier-25-denials","status":"publish","type":"wpseo_locations","link":"https:\/\/www.medicalbillersandcoders.com\/blog\/locations\/obgyn-billing-in-texas-facing-rising-modifier-25-denials\/","title":{"rendered":"OB-GYN Billing in Texas Facing Rising Modifier 25 Denials"},"content":{"rendered":"

OBGYN billing in Texas<\/strong> is under pressure from two converging revenue cycle problems in 2026, and practices across the state are seeing the financial impact in their monthly denial reports. The first is Modifier 25 \u2014 the most frequently audited modifier in the specialty, now carrying a new denial trigger tied to the 2026 G2211 conflict rule that most practices have not yet addressed. The second is a wave of state-level Medicaid postpartum policy changes that have created a 12-month coverage window in 49 states \u2014 most practices are not billing correctly because their workflows still reflect the old 60-day rule.<\/p>\r\n

OB-GYN denial rates average between 18 and 22% nationally. In Texas, the combination of five competing Medicaid MCOs, aggressive commercial payer AI audits, and strict, timely filing windows pushes that number higher. Both issues are structural contributors \u2014 and both are correctable once the root cause is identified.<\/p>\r\n

Modifier 25 in OB-GYN: Why Denials Are Rising \u2014 Especially in Texas<\/h2>\r\n

Modifier 25 signals that a provider performed a significant, separately identifiable evaluation and management (E\/M) service on the same day as a procedure. In OB-GYN, this scenario is routine \u2014 a patient presents for a well-woman exam, and the provider also evaluates a new complaint; a patient comes in for an IUD insertion, and a separate clinical issue is addressed during the same visit. Both services are legitimately billable, but only with Modifier 25 correctly applied to the E\/M.<\/p>\r\n

In 2026, CMS identified Modifier 25 as a primary target for Targeted Probe and Educate (TPE) audits \u2014 alongside Modifiers 59 and 24. For\u00a0OB-GYN billing in Texas<\/strong><\/a>, this matters acutely because the state’s five Medicaid MCOs and multiple dominant commercial payers each apply different same-day billing rules. Payer algorithms now flag practices where the modifier appears on nearly every procedure-day encounter, treating it as systematic misuse rather than clinical judgment. The financial risk runs in both directions: missing the modifier loses legitimate revenue, while applying it without sufficient documentation creates audit and recoupment exposure.<\/p>\r\n

\r\n

New in 2026 \u2014 the G2211 conflict.<\/strong> CMS guidelines prohibit billing the G2211 complexity add-on on the same day as an E\/M that carries Modifier 25 for a minor procedure with a 0-day global period. OB-GYN practices that routinely bill G2211 on office visits that also include colposcopy, IUD insertion, LEEP, or cryotherapy are generating systematic denials on previously clean encounters as of January 1, 2026.<\/p>\r\n<\/div>\r\n

The three Modifier 25 errors that drive the most OB-GYN denials<\/h3>\r\n